1. Home
  2. INVE vs ANVS Comparison

INVE vs ANVS Comparison

Compare INVE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVE
  • ANVS
  • Stock Information
  • Founded
  • INVE 1990
  • ANVS 2008
  • Country
  • INVE United States
  • ANVS United States
  • Employees
  • INVE N/A
  • ANVS N/A
  • Industry
  • INVE Computer peripheral equipment
  • ANVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVE Technology
  • ANVS Health Care
  • Exchange
  • INVE Nasdaq
  • ANVS Nasdaq
  • Market Cap
  • INVE 86.5M
  • ANVS 92.6M
  • IPO Year
  • INVE 1997
  • ANVS 2020
  • Fundamental
  • Price
  • INVE $3.48
  • ANVS $2.95
  • Analyst Decision
  • INVE Strong Buy
  • ANVS Strong Buy
  • Analyst Count
  • INVE 2
  • ANVS 6
  • Target Price
  • INVE $7.25
  • ANVS $29.67
  • AVG Volume (30 Days)
  • INVE 39.5K
  • ANVS 535.2K
  • Earning Date
  • INVE 03-11-2025
  • ANVS 03-31-2025
  • Dividend Yield
  • INVE N/A
  • ANVS N/A
  • EPS Growth
  • INVE N/A
  • ANVS N/A
  • EPS
  • INVE 3.10
  • ANVS N/A
  • Revenue
  • INVE $104,217,000.00
  • ANVS N/A
  • Revenue This Year
  • INVE N/A
  • ANVS N/A
  • Revenue Next Year
  • INVE N/A
  • ANVS N/A
  • P/E Ratio
  • INVE $1.12
  • ANVS N/A
  • Revenue Growth
  • INVE 70.57
  • ANVS N/A
  • 52 Week Low
  • INVE $2.95
  • ANVS $2.88
  • 52 Week High
  • INVE $9.24
  • ANVS $20.00
  • Technical
  • Relative Strength Index (RSI)
  • INVE 43.25
  • ANVS 20.82
  • Support Level
  • INVE $3.50
  • ANVS $2.99
  • Resistance Level
  • INVE $3.82
  • ANVS $5.50
  • Average True Range (ATR)
  • INVE 0.18
  • ANVS 0.34
  • MACD
  • INVE -0.01
  • ANVS -0.18
  • Stochastic Oscillator
  • INVE 21.82
  • ANVS 3.59

About INVE Identiv Inc.

Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

Share on Social Networks: